Certain Stock Options of Lucid Diagnostics Inc. are subject to a Lock-Up Agreement Ending on 12-APR-2022. These Stock Options will be under lockup for 181 days starting from 13-OCT-2021 to 12-APR-2022.

Details:
The company's officers and directors have agreed not to sell, offer, contract or grant any option to sell (including any short sale), pledge, transfer, establish an open “put equivalent position” within the meaning of Rule 16a-l(h) under the Securities Exchange Act of 1934, as amended, or otherwise dispose of, any shares of common stock, options or warrants to acquire shares of common stock, or securities exchangeable or exercisable for or convertible into shares of common stock currently or hereafter owned either of record or beneficially for a period of 180 days after the date of the underwriting agreement without the prior written consent of the Representatives.